PLAY PODCASTS
Gene Editing Tech Risks and Rewards: Dr. Jennifer Doudna's Perspective
Episode 147

Gene Editing Tech Risks and Rewards: Dr. Jennifer Doudna's Perspective

In a wide-ranging interview with Ian Bremmer, Nobel Prize-winning scientist Jennifer Doudna discusses her groundbreaking work on the revolutionary gene-editing technology known as CRISPR. In their conversation she explains what CRISPR is and why it has the potential to cure diseases and fend off viruses. She also talks about the limits of this technology and advocates for a global policy consensus on what limitations there should be around gene editing. Policymakers must also factor in income inequality, Doudna argues, given how expensive CRISPR currently is and the potential it has to change so many lives.

GZERO World with Ian Bremmer

August 21, 202124m 58s

Audio is streamed directly from the publisher (afp-297669-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In a wide-ranging interview with Ian Bremmer, Nobel Prize-winning scientist Jennifer Doudna discusses her groundbreaking work on the revolutionary gene-editing technology known as CRISPR. In their conversation she explains what CRISPR is and why it has the potential to cure diseases and fend off viruses. She also talks about the limits of this technology and advocates for a global policy consensus on what limitations there should be around gene editing. Policymakers must also factor in income inequality, Doudna argues, given how expensive CRISPR currently is and the potential it has to change so many lives.  

Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

geneticsnobelgzerogenebremmerdoudnadnacloninggenomecrisprscience